PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1989; 82(Suppl 17): 44–51.
PMCID: PMC1291940

Treatment of severe malaria.

Abstract

In the treatment of severe Plasmodium falciparum infection antimalarial drugs should, ideally, be given by controlled rate intravenous infusion until the patient is able to swallow tablets. In cases where infection has been acquired in a chloroquine resistant area, and where it has broken through chloroquine prophylaxis or where the geographical origin or species are uncertain, quinine is the treatment of choice. When access to parenteral quinine is likely to be delayed, parenteral quinidine is an effective alternative. A loading dose of quinine is recommended in order to achieve therapeutic plasma concentrations as quickly as possible. In the case of chloroquine sensitive P. falciparum infection, chloroquine, which can be given safely by slow intravenous infusion, may be more rapidly effective and has fewer toxic effects than quinine. There is limited experience with parenteral administration of pyrimethamine sulphonamide combinations such as Fansidar, and resistance to these drugs has developed in South East Asia and elsewhere. Mefloquine and halofantrine cannot be given parenterally. Qinghaosu derivatives are not readily available and have not been adequately tested outside China. Supportive treatment includes the prevention or early detection and treatment of complications, strict attention to fluid balance, provision of adequate nursing for unconscious patients and avoidance of harmful ancillary treatments. Anaemia is inevitable and out of proportion to detectable parasitaemia. Hypotension and shock ('algid malaria') are often attributable to secondary gram-negative septicaemia requiring appropriate antimicrobial therapy and haemodynamic resuscitation. Many patients with severe falciparum malaria are hypovolaemic on admission to hospital and require cautious fluid replacement. Failure to rehydrate these patients may lead to circulatory collapse, lactic acidosis, renal failure and severe hyponatraemia.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.6M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Bruce-Chwatt LJ. Unde venis viator et quo vadis? Ann Trop Med Parasitol. 1987 Oct;81(5):471–486. [PubMed]
  • Molyneux ME, Taylor TE, Wirima JJ, Borgstein A. Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q J Med. 1989 May;71(265):441–459. [PubMed]
  • White NJ, Looareesuwan S, Phillips RE, Chanthavanich P, Warrell DA. Single dose phenobarbitone prevents convulsions in cerebral malaria. Lancet. 1988 Jul 9;2(8602):64–66. [PubMed]
  • White NJ, Looareesuwan S, Warrell DA, Warrell MJ, Chanthavanich P, Bunnag D, Harinasuta T. Quinine loading dose in cerebral malaria. Am J Trop Med Hyg. 1983 Jan;32(1):1–5. [PubMed]
  • Chongsuphajaisiddhi T, Sabcharoen A, Attanath P. In vivo and in vitro sensitivity of Falciparum malaria to quinine in Thai children. Ann Trop Paediatr. 1981 Mar;1(1):21–26. [PubMed]
  • Greenberg AE, Nguyen-Dinh P, Davachi F, Yemvula B, Malanda N, Nzeza M, Williams SB, de Zwart JF, Nzeza M. Intravenous quinine therapy of hospitalized children with Plasmodium falciparum malaria in Kinshasa, Zaire. Am J Trop Med Hyg. 1989 Apr;40(4):360–364. [PubMed]
  • Davis TM, White NJ, Looareesuwan S, Silamut K, Warrell DA. Quinine pharmacokinetics in cerebral malaria: predicted plasma concentrations after rapid intravenous loading using a two-compartment model. Trans R Soc Trop Med Hyg. 1988;82(4):542–547. [PubMed]
  • Edwards G, Davies AJ, Phillips RE, Looareesuwan S, Karbwang J, White NJ, Warrell DA. Plasma concentrations and toxicity of chloroquine after slow intravenous infusion in patients with falciparum malaria. Ann Trop Med Parasitol. 1987 Apr;81(2):79–84. [PubMed]
  • Edwards G, Looareesuwan S, Davies AJ, Wattanagoon Y, Phillips RE, Warrell DA. Pharmacokinetics of chloroquine in Thais: plasma and red-cell concentrations following an intravenous infusion to healthy subjects and patients with Plasmodium vivax malaria. Br J Clin Pharmacol. 1988 Apr;25(4):477–485. [PMC free article] [PubMed]
  • Phillips RE, Warrell DA, Edwards G, Galagedera Y, Theakston RD, Abeysekera DT, Dissanayaka P. Divided dose intramuscular regimen and single dose subcutaneous regimen for chloroquine: plasma concentrations and toxicity in patients with malaria. Br Med J (Clin Res Ed) 1986 Jul 5;293(6538):13–16. [PMC free article] [PubMed]
  • White NJ, Watt G, Bergqvist Y, Njelesani EK. Parenteral chloroquine for treating falciparum malaria. J Infect Dis. 1987 Feb;155(2):192–201. [PubMed]
  • White NJ, Miller KD, Churchill FC, Berry C, Brown J, Williams SB, Greenwood BM. Chloroquine treatment of severe malaria in children. Pharmacokinetics, toxicity, and new dosage recommendations. N Engl J Med. 1988 Dec 8;319(23):1493–1500. [PubMed]
  • Chongsuphajaisiddhi T, Dauruag V, Patcharakessakul V, Kittivattanakul V, Dulyasakdi B, Ridthimat W. Treatment of falciparum malaria with intra muscular quinine in a rural area of Thailand. Southeast Asian J Trop Med Public Health. 1983 Jun;14(2):220–222. [PubMed]
  • Shann F, Stace J, Edstein M. Pharmacokinetics of quinine in children. J Pediatr. 1985 Mar;106(3):506–510. [PubMed]
  • Wattanagoon Y, Phillips RE, Warrell DA, Silamut K, Looareesuwan S, Nagachinta B, Back DJ. Intramuscular loading dose of quinine for falciparum malaria: pharmacokinetics and toxicity. Br Med J (Clin Res Ed) 1986 Jul 5;293(6538):11–13. [PMC free article] [PubMed]
  • Chanthavanich P, Looareesuwan S, White NJ, Warrell DA, Warrell MJ, DiGiovanni JH, von Bredow J. Intragastric mefloquine is absorbed rapidly in patients with cerebral malaria. Am J Trop Med Hyg. 1985 Nov;34(6):1028–1036. [PubMed]
  • Lataste P, Soubiran G, Nlend A, Le Bras M, Roue R, Wone C, Ragnaud JC, Buil A, Briand MC, Ripert C, et al. Intérêt de l'exsanguinotransfusion dans le traitement du paludisme grave (à propos de 5 observations). Bull Soc Pathol Exot Filiales. 1987;80(3 Pt 2):561–568. [PubMed]
  • Harinasuta T, Viravan C, Buranasin P. Parenteral Fansidar in falciparum malaria. Trans R Soc Trop Med Hyg. 1988;82(5):694–694. [PubMed]
  • Li GQ, Guo XB, Jin R, Wang ZC, Jian HX, Li ZY. Clinical studies on treatment of cerebral malaria with qinghaosu and its derivatives. J Tradit Chin Med. 1982 Jun;2(2):125–130. [PubMed]
  • White NJ, Chanthavanich P, Krishna S, Bunch C, Silamut K. Quinine disposition kinetics. Br J Clin Pharmacol. 1983 Oct;16(4):399–403. [PMC free article] [PubMed]
  • White NJ, Looareesuwan S, Warrell DA. Quinine and quinidine: a comparison of EKG effects during the treatment of malaria. J Cardiovasc Pharmacol. 1983 Mar-Apr;5(2):173–175. [PubMed]
  • Phillips RE, Warrell DA, White NJ, Looareesuwan S, Karbwang J. Intravenous quinidine for the treatment of severe falciparum malaria. Clinical and pharmacokinetic studies. N Engl J Med. 1985 May 16;312(20):1273–1278. [PubMed]
  • White NJ, Warrell DA, Chanthavanich P, Looareesuwan S, Warrell MJ, Krishna S, Williamson DH, Turner RC. Severe hypoglycemia and hyperinsulinemia in falciparum malaria. N Engl J Med. 1983 Jul 14;309(2):61–66. [PubMed]
  • Looareesuwan S, Phillips RE, White NJ, Kietinun S, Karbwang J, Rackow C, Turner RC, Warrell DA. Quinine and severe falciparum malaria in late pregnancy. Lancet. 1985 Jul 6;2(8445):4–8. [PubMed]
  • Phillips RE, Looareesuwan S, White NJ, Silamut K, Kietinun S, Warrell DA. Quinine pharmacokinetics and toxicity in pregnant and lactating women with falciparum malaria. Br J Clin Pharmacol. 1986 Jun;21(6):677–683. [PMC free article] [PubMed]
  • Riou B, Barriot P, Rimailho A, Baud FJ. Treatment of severe chloroquine poisoning. N Engl J Med. 1988 Jan 7;318(1):1–6. [PubMed]
  • Looareesuwan S, Merry AH, Phillips RE, Pleehachinda R, Wattanagoon Y, Ho M, Charoenlarp P, Warrell DA, Weatherall DJ. Reduced erythrocyte survival following clearance of malarial parasitaemia in Thai patients. Br J Haematol. 1987 Dec;67(4):473–478. [PubMed]
  • Taylor TE, Molyneux ME, Wirima JJ, Fletcher KA, Morris K. Blood glucose levels in Malawian children before and during the administration of intravenous quinine for severe falciparum malaria. N Engl J Med. 1988 Oct 20;319(16):1040–1047. [PubMed]
  • Phillips RE, Warrell DA, Looareesuwan S, Turner RC, Bloom SR, Quantrill D, Moore AR. Effectiveness of SMS 201-995, a synthetic, long-acting somatostatin analogue, in treatment of quinine-induced hyperinsulinaemia. Lancet. 1986 Mar 29;1(8483):713–716. [PubMed]
  • Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974 Jul 13;2(7872):81–84. [PubMed]
  • Warrell DA. Pathophysiology of severe falciparum malaria in man. Parasitology. 1987;94 (Suppl):S53–S76. [PubMed]
  • Horstmann RD, Ehrich JH, Beck J, Dietrich M. Letale Komplikationen der Malaria tropica bei Nichtimmunen. Eine retrospektive klinisch-pathologische Analyse von 25 Fällen. Dtsch Med Wochenschr. 1985 Oct 25;110(43):1651–1656. [PubMed]
  • Warrell DA, Looareesuwan S, Warrell MJ, Kasemsarn P, Intaraprasert R, Bunnag D, Harinasuta T. Dexamethasone proves deleterious in cerebral malaria. A double-blind trial in 100 comatose patients. N Engl J Med. 1982 Feb 11;306(6):313–319. [PubMed]
  • Hoffman SL, Rustama D, Punjabi NH, Surampaet B, Sanjaya B, Dimpudus AJ, McKee KT, Jr, Paleologo FP, Campbell JR, Marwoto H, et al. High-dose dexamethasone in quinine-treated patients with cerebral malaria: a double-blind, placebo-controlled trial. J Infect Dis. 1988 Aug;158(2):325–331. [PubMed]
  • Rees P. Dexamethasone deleterious in cerebral malaria. Br Med J (Clin Res Ed) 1982 Nov 6;285(6351):1357–1357. [PMC free article] [PubMed]
  • Cooper B. High-dose dexamethasone in malaria. J Infect Dis. 1989 Apr;159(4):803–804. [PubMed]
  • Sprung CL, Caralis PV, Marcial EH, Pierce M, Gelbard MA, Long WM, Duncan RC, Tendler MD, Karpf M. The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med. 1984 Nov 1;311(18):1137–1143. [PubMed]
  • Poungvarin N, Bhoopat W, Viriyavejakul A, Rodprasert P, Buranasiri P, Sukondhabhant S, Hensley MJ, Strom BL. Effects of dexamethasone in primary supratentorial intracerebral hemorrhage. N Engl J Med. 1987 May 14;316(20):1229–1233. [PubMed]
  • Bone RC, Fisher CJ, Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med. 1987 Sep 10;317(11):653–658. [PubMed]
  • Weston MJ, Jackman N, Rudge C, Bowles J, Brady C, Bielawska C, O'Grady J. Prostacyclin in Falciparum malaria. Lancet. 1982 Sep 11;2(8298):609–609. [PubMed]
  • Brooks MH, Malloy JP, Bartelloni PJ, Tigertt WD, Sheehy TW, Barry KG. Pathophysiology of acute falciparum malaria. I. Correlation of clinical and biochemical abnormalities. Am J Med. 1967 Nov;43(5):735–744. [PubMed]
  • Malloy JP, Brooks MH, Barry KG. Pathophysiology of acute falciparum malaria. II. Fluid compartmentalization. Am J Med. 1967 Nov;43(5):745–750. [PubMed]
  • Chongsuphajaisiddhi T, Kasemsuth R, Tejavanija S, Harinasuta T. Changes in blood volume in Falciparum malaria. Southeast Asian J Trop Med Public Health. 1971 Sep;2(3):344–350. [PubMed]
  • Stacpoole PW, Lorenz AC, Thomas RG, Harman EM. Dichloroacetate in the treatment of lactic acidosis. Ann Intern Med. 1988 Jan;108(1):58–63. [PubMed]
  • Miller KD, Greenberg AE, Campbell CC. Treatment of severe malaria in the United States with a continuous infusion of quinidine gluconate and exchange transfusion. N Engl J Med. 1989 Jul 13;321(2):65–70. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press